ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter: +11.81%
1-year: -6.13%
3-year: +68.78%
5-year: +54.42%
3-year vs S&P 500: -4.46%
5-year vs S&P 500: -19.26%
5-year top 5: +37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Filing period

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 4 of 14 rows. Rows without a quote are marked unavailable.


1	VRX	VALEANT PHARMACEUTICALS INTL COM	22.29%	-	17,775,903	$565.1M	No quote	No quote
2	SLE	SARA LEE CORP COM	16.77%	-	34,918,822	$425.31M	No quote	No quote
3	IT	GARTNER GROUP INC NEW-CL A COM	14.79%	-	20,790,013	$375.05M	$18.04	No quote
4	BCR	C R BARD INC COM	8.09%	-	2,634,500	$205.23M	No quote	No quote
5	MDZ	MDS INC COM	6.97%	-	23,107,700	$176.77M	No quote	No quote
6	BFH	ALLIANCE DATA SYSTEM CORP COM	6.58%	-	2,583,900	$166.89M	$64.59	No quote
7	WSH	WILLIS GROUP HOLDINGS LTD SHS	6.23%	-	5,990,410	$158.03M	No quote	No quote
8	IMA	INVERNESS MEDICAL INNOVATIONS COM	5.59%	-	3,413,782	$141.71M	No quote	No quote
9	BLUD	IMMUCOR INC COM	3.56%	-	4,457,779	$90.23M	No quote	No quote
10	VRSN	VERISIGN INC COM	3.48%	-	3,645,017	$88.36M	$24.24	No quote
11	SNA	SNAP ON TOOLS CORP COM	1.97%	-	1,180,609	$49.89M	$42.26	No quote
12	WCRX	WARNER CHILCOTT LIMITED COM	1.94%	-	1,726,848	$49.16M	No quote	No quote
13	KAR	KAR AUCTION SERVICES INC COM	1.23%	-	2,258,828	$31.15M	No quote	No quote
14	IMAPRB	INVERNESS MEDICAL INNOVATIONS PFDCONVSERB	0.50%	-	47,195	$12.67M	No quote	No quote